Orally Administered Recombinant Human Interleukin-11 Is Protective in Experimental Neutropenic Sepsis

http://www.100md.com 《传染病学杂志》 2003年第1期

OrallyAdministeredRecombinantHumanInterleukin-11IsProtectiveinExperimentalNeutropenicSepsis,Recombinanthumaninterleukin(IL)–,11isamultifunctionalcytokinewithhematopoietic,immunomodulatory,andepithelialcellprotectiveactivities.IL-11α,receptorsareexpressedonth

    百拇医药网 http://www.100md.com/html/DirDu/2005/05/06/58/21/26.htm

您现在查看是摘要页，全文长 34010 字符。